Email updates

Keep up to date with the latest news and content from AIDS Research and Therapy and BioMed Central.

Open Access Highly Accessed Research

The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China

Yuelan Shen, Bin Su*, Jianjun Wu, Yizu Qin, Lin Jin, Lifeng Miao, Aiwen Liu and Xiaoli Cheng

Author Affiliations

Department of HIV&AIDS, Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, Anhui, China

For all author emails, please log on.

AIDS Research and Therapy 2014, 11:19  doi:10.1186/1742-6405-11-19

Published: 8 July 2014

Abstract

Background

To optimize treatment regimens, we assessed human immunodeficiency virus (HIV) diversity and the prevalence of transmitted drug resistance (TDR) among men who have sex with men (MSM) in Anhui province, China.

Methods

A total of 139 MSM who were newly diagnosed and antiretroviral treatment-naive were enrolled in Anhui in 2011. A partial pol fragment was amplified and sequenced, and HIV subtypes were determined by phylogenetic analyses. Surveillance/transmitted drug resistance mutations (SDRMs) were identified according to the 2009 World Health Organization (WHO) list.

Results

A total of 133 (95.7%) samples were successfully amplified and sequenced. Based on phylogenetic analyses of the pol fragment, CRF01_AE accounted for 55.6% (74/133) of the infections, followed by CRF07_BC with 32.3% (43/133), B with 5.3% (7/133), and unique recombinant forms with 6.8% (9/133). A total of 3.0% (4/133) of the subjects were found to harbor HIV variants with SDRMs, including 1.5% with NRTI-related mutations and 1.5% with NNRTI-related mutations. PI-related mutations were absent. The SDRMs included L210W (1.5%), Y181C (0.8%), and G190A (0.8%).

Conclusions

In Anhui, CRF01_AE strains contributed to most of the HIV infections among MSM, and the prevalence of TDR was relatively low in this population. Further studies should be performed to evaluate the trend of TDR among MSM in Anhui and to inform first-line antiretroviral treatment.

Keywords:
HIV; Prevalence; Transmitted drug resistance; Treatment-naive; MSM